CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-09 | Heino Mary Anne Director | Grant or award | +2,635 | 424,144 | ||
| 2024-05-09 | Heino Mary Anne Director | Grant or award · Stock Option (right to buy) | +4,853 | 4,853 | ||
| 2024-04-17 | Niedzwiecki Daniel See Remarks | Shares withheld for taxes | −177 | $61.48 | $11K | 94,583 |
| 2024-04-17 | Blanchfield Paul President | Shares withheld for taxes | −455 | $61.48 | $28K | 102,677 |
| 2024-04-15 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −341 | $61.24 | $21K | 63,239 |
| 2024-03-15 | Marshall Robert J. Jr. CFO and Treasurer | Sale 10b5-1 | −20,000 | $60.00 | $1.2M | 113,749 |
| 2024-03-13 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −341 | $60.48 | $21K | 63,204 |
| 2024-03-07 | Blanchfield Paul President | Sale 10b5-1 | −18,023 | $61.96 | $1.1M | 103,357 |
| 2024-03-07 | Blanchfield Paul President | Gift 10b5-1 | −500 | 102,857 | ||
| 2024-03-06 | LENO SAM R Director | Option exercise 10b5-1 | +2,045 | $16.30 | $33K | 59,982 |
| 2024-03-06 | LENO SAM R Director | Sale 10b5-1 | −529 | $62.12 | $33K | 59,453 |
| 2024-03-06 | LENO SAM R Director | Sale 10b5-1 | −400 | $63.26 | $25K | 59,053 |
| 2024-03-06 | LENO SAM R Director | Sale 10b5-1 | −1,116 | $64.24 | $72K | 57,937 |
| 2024-03-06 | LENO SAM R Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,045 | 0 | ||
| 2024-03-05 | LENO SAM R Director | Option exercise 10b5-1 | +2,045 | $16.30 | $33K | 59,982 |
| 2024-03-05 | LENO SAM R Director | Sale 10b5-1 | −1,729 | $64.47 | $111K | 58,253 |
| 2024-03-05 | LENO SAM R Director | Sale 10b5-1 | −316 | $65.44 | $21K | 57,937 |
| 2024-03-05 | LENO SAM R Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,045 | 0 | ||
| 2024-03-05 | Blanchfield Paul President | Shares withheld for taxes | −20,728 | $65.36 | $1.4M | 121,380 |
| 2024-03-05 | Sabens Andrea Chief Accounting Officer | Shares withheld for taxes | −6,360 | $65.36 | $416K | 63,545 |
Page 10 of 19 · 376 trades